Researchers compared the safety and efficacy of BrECADD vs eBEACOPP, a standard regimen, in the newly diagnosed, advanced-stage classical HL setting.

Suzanne is a content marketer, writer, and fact-checker. She holds a Bachelor of Science in Finance degree from Bridgewater State University and helps develop content strategies. Technical analysis is ...

Julie Young is an experienced financial writer and editor. She specializes in financial analysis in capital planning and investment management. Gordon Scott has been an active investor and technical ...